NCT00428220 2019-06-27
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
Pfizer
Phase NA Completed
Clinical Trials
14 trialsNCT00662025 2013-05-27
Study Of Sunitinib With Capecitabine In Breast Cancer
Pfizer
Phase 2 Completed
NCT00372424 2012-12-28
Study Of SU011248 In Combination With Docetaxel And Trastuzumab In Patients With Advanced Breast Cancer HER-2 Positive
Pfizer
Phase 1 Completed
NCT00393939 2012-07-19
SUN 1064
Pfizer
Phase 3 Completed
NCT00246571 2012-07-12
Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer
Pfizer
Phase 2 Completed
NCT00435409 2012-06-26
A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer
Pfizer
Phase 3 Completed
NCT00373113 2012-06-25
A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine
Pfizer
Phase 3 Terminated
NCT00471276 2011-07-25
Efficacy And Safety Of Sunitinib In Women With Advanced Breast Cancer
Pfizer
Phase 2 Completed
NCT00243503 2011-07-22
Open Label Study Of SU011248 In Combination With Trastuzumab For Patients With Metastatic Breast Cancer
Pfizer
Phase 2 Completed
NCT00417885 2010-09-21
A Clinical Trial Assessing Efficacy and Safety of Sunitinib and Exemestane in Patients With ER [Estrogen Receptor] + and/or PgR [Progesterone Receptor] + Breast Cancer
Pfizer
Phase 1/2 Terminated
NCT00291577 2009-12-23
Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast Cancer
Pfizer
Phase 1 Completed
NCT00434356 2009-12-03
A Study of Sunitinib in Combination With Bevacizumab and Paclitaxel in Previously Untreated Patients With Metastatic Breast Cancer (SABRE-B)
Genentech, Inc.
Phase 2 Terminated
NCT00174434 2009-01-27
Study Of SU011248 In Combination With Paclitaxel In Patients With Metastatic Breast Cancer
Pfizer
Phase 1 Completed
NCT00078000 2008-11-26
A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.
Pfizer
Phase 2 Completed